NRIX
Price
$14.33
Change
+$1.65 (+13.01%)
Updated
Nov 19 closing price
Capitalization
1.45B
90 days until earnings call
Intraday BUY SELL Signals
RARE
Price
$31.86
Change
-$0.97 (-2.95%)
Updated
Nov 19 closing price
Capitalization
3.07B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs RARE

Header iconNRIX vs RARE Comparison
Open Charts NRIX vs RAREBanner chart's image
Nurix Therapeutics
Price$14.33
Change+$1.65 (+13.01%)
Volume$1.68M
Capitalization1.45B
Ultragenyx Pharmaceutical
Price$31.86
Change-$0.97 (-2.95%)
Volume$1.07M
Capitalization3.07B
NRIX vs RARE Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
RARE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. RARE commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and RARE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NRIX: $14.34 vs. RARE: $31.85)
Brand notoriety: NRIX and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 107% vs. RARE: 70%
Market capitalization -- NRIX: $1.45B vs. RARE: $3.07B
NRIX [@Biotechnology] is valued at $1.45B. RARE’s [@Biotechnology] market capitalization is $3.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 4 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 5 bearish.
  • RARE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both NRIX and RARE are a bad buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а +17.83% price change this week, while RARE (@Biotechnology) price change was -5.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

RARE is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.07B) has a higher market cap than NRIX($1.45B). NRIX (-23.885) and RARE (-24.293) have similar YTD gains . NRIX has higher annual earnings (EBITDA): -248.7M vs. RARE (-435.33M). RARE has more cash in the bank: 477M vs. NRIX (429M). RARE has less debt than NRIX: RARE (36.3M) vs NRIX (56.5M). RARE has higher revenues than NRIX: RARE (610M) vs NRIX (83.7M).
NRIXRARENRIX / RARE
Capitalization1.45B3.07B47%
EBITDA-248.7M-435.33M57%
Gain YTD-23.885-24.29398%
P/E RatioN/AN/A-
Revenue83.7M610M14%
Total Cash429M477M90%
Total Debt56.5M36.3M156%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXRARE
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 13 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
RARE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MBCNX17.40N/A
N/A
MassMutual Blue Chip Growth R3
TRGPX21.78N/A
N/A
Nuveen Quant Mid Cap Growth Premier
SDFSX18.12N/A
N/A
Sit Small Cap Dividend Growth S
VRTPX21.47N/A
N/A
Vanguard Real Estate II Index
ZEMAX14.59-0.03
-0.21%
American Beacon Ninety One Emr Mkts Eq Y